ONPH
Price:
$0.0001
Market Cap:
$273.90K
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.[Read more]
Industry
Biotechnology
IPO Date
1994-10-31
Stock Exchange
PNK
Ticker
ONPH
According to Oncology Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.69% compared to the average of -3.20 of the last 4 quarters.
The mean historical PE Ratio of Oncology Pharma Inc. over the last ten years is -144.46. The current -0.01 PE Ratio has changed -99.31% with respect to the historical average. Over the past ten years (40 quarters), ONPH's PE Ratio was at its highest in in the March 1999 quarter at 0. The PE Ratio was at its lowest in in the December 1999 quarter at -2321.43.
Average
-144.46
Median
-16.08
Minimum
-1078.97
Maximum
0
Discovering the peaks and valleys of Oncology Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 357.27%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -1078.97
Year | PE Ratio | Change |
---|---|---|
2023 | 0 | -100.00% |
2022 | -1.09 | -64.36% |
2021 | -3.05 | -81.18% |
2020 | -16.19 | 357.27% |
2019 | -3.54 | -77.83% |
2004 | -15.97 | -53.75% |
2003 | -34.54 | -77.54% |
2002 | -153.77 | 11.88% |
2001 | -137.44 | -87.26% |
2000 | -1078.97 | -Infinity% |
The current PE Ratio of Oncology Pharma Inc. (ONPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.38
5-year avg
-4.77
10-year avg
-144.46
Oncology Pharma Inc.’s PE Ratio is greater than Regen BioPharma, Inc. (-0.73), greater than Propanc Biopharma, Inc. (-0.06), less than Kaleido Biosciences, Inc. (0), less than RegeneRx Biopharmaceuticals, Inc. (0), greater than Regen BioPharma, Inc. (-1.89), less than Therapeutic Solutions International, Inc. (-0.00), greater than Alpha Cognition Inc. (-3.56), less than HAVN Life Sciences Inc. (0), greater than Surrozen, Inc. (-0.70), greater than Jasper Therapeutics, Inc. (-5.29), greater than Revelation Biosciences, Inc. (-0.09), greater than Wesana Health Holdings Inc. (-0.56), greater than Living Cell Technologies Limited (-3.61), greater than MultiCell Technologies, Inc. (-0.10), greater than Institute of Biomedical Research Corp. (-0.08), less than Health Sciences Group, Inc. (0), greater than Mymetics Corporation (-0.03), greater than Anebulo Pharmaceuticals, Inc. (-5.95), greater than Aerovate Therapeutics, Inc. (-0.89), greater than Acrivon Therapeutics, Inc. Common Stock (-4.11), greater than Opthea Limited (-1.53), greater than AN2 Therapeutics, Inc. (-0.50),
Company | PE Ratio | Market cap |
---|---|---|
-0.73 | $377.63K | |
-0.06 | $180.86K | |
0 | $4.26K | |
0 | $2.10K | |
-1.89 | $14.55M | |
-0.00 | $3.66M | |
-3.56 | $57.93M | |
0 | $553.11K | |
-0.70 | $42.41M | |
-5.29 | $321.43M | |
-0.09 | $3.09M | |
-0.56 | $171.26K | |
-3.61 | $7.17M | |
-0.10 | $50.01K | |
-0.08 | $9.60M | |
0 | $187.09K | |
-0.03 | $303.76K | |
-5.95 | $49.01M | |
-0.89 | $78.52M | |
-4.11 | $243.13M | |
-1.53 | $628.43M | |
-0.50 | $32.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncology Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncology Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Oncology Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for Oncology Pharma Inc. (ONPH)?
What is the highest PE Ratio for Oncology Pharma Inc. (ONPH)?
What is the 3-year average PE Ratio for Oncology Pharma Inc. (ONPH)?
What is the 5-year average PE Ratio for Oncology Pharma Inc. (ONPH)?
How does the current PE Ratio for Oncology Pharma Inc. (ONPH) compare to its historical average?